Celularity Inc. CELU
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -71.09M | -91.72M | -80.65M | -73.67M | -55.63M |
| Total Depreciation and Amortization | 5.15M | 5.38M | 7.32M | 7.44M | 7.60M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.41M | 39.60M | 31.42M | 24.49M | 14.57M |
| Change in Net Operating Assets | 25.72M | 33.47M | 35.36M | 39.20M | 28.47M |
| Cash from Operations | -8.81M | -13.25M | -6.56M | -2.54M | -4.99M |
| Capital Expenditure | -- | -- | -91.00K | -91.00K | -122.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -1.50M | -1.50M | -1.50M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | 2.18M |
| Cash from Investing | -- | -- | -1.59M | -1.59M | 553.00K |
| Total Debt Issued | 16.81M | 16.81M | 7.44M | 629.00K | 629.00K |
| Total Debt Repaid | -13.02M | -6.02M | -6.05M | -123.00K | -178.00K |
| Issuance of Common Stock | 3.14M | 5.60M | 5.60M | 3.47M | 2.46M |
| Repurchase of Common Stock | -3.13M | -3.23M | -21.14M | -21.13M | -21.12M |
| Issuance of Preferred Stock | 2.00M | 2.00M | 6.00M | 6.00M | 6.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.18M | 3.48M | 16.22M | 15.67M | 15.00M |
| Cash from Financing | 8.99M | 18.65M | 8.07M | 4.52M | 2.79M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 173.00K | 5.40M | -76.00K | 382.00K | -1.64M |